Literature DB >> 25737058

Relationship of age of onset and family history in Parkinson disease.

Matthew J Barrett1, Nicholas E Hac, Guofen Yan, Madaline B Harrison, G Frederick Wooten.   

Abstract

BACKGROUND: The aim of this study was to determine whether age of onset of Parkinson disease (PD) is associated with differences in PD risk and PD age of onset in parents and siblings.
METHODS: Clinical and detailed family history data were available for 1,114 PD probands.
RESULTS: Proband age of onset was not associated with differences in PD prevalence or PD age of onset in parents. Proband age of PD onset <50, compared with ≥ 50 years, was associated with significantly greater risk of PD in siblings (hazard ratio: 2.4; P=0.002; 95% confidence interval: 1.4, 4.1), and proband age of onset was significantly correlated with sibling age of onset (Somer's D=0.20; P=0.018).
CONCLUSIONS: Proband age of PD onset is not associated with differences in parental PD risk. Siblings of PD patients with onset before age 50 are at increased risk of PD and are more likely to have early-onset disease.
© 2015 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson disease; age of onset; familial aggregation; family history; genetics

Mesh:

Year:  2015        PMID: 25737058     DOI: 10.1002/mds.26166

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  4 in total

1.  Investigation of Nonmotor Symptoms in First-Degree Relatives of Patients with Different Clinical Types of Parkinson's Disease.

Authors:  Jiang-Bing Liu; Jun-Ling Leng; Ying-Ge Wang; Yu Zhang; Tie-Yu Tang; Li-Hong Tao; Xin-Jiang Zhang; Chun-Feng Liu
Journal:  Parkinsons Dis       Date:  2019-01-02

2.  Does a rare mutation in PTPRA contribute to the development of Parkinson's disease in an Australian multi-incident family?

Authors:  Melissa A Hill; Steven R Bentley; Tara L Walker; George D Mellick; Stephen A Wood; Alex M Sykes
Journal:  PLoS One       Date:  2022-07-28       Impact factor: 3.752

3.  microRNA Profiles in Parkinson's Disease Prefrontal Cortex.

Authors:  Andrew G Hoss; Adam Labadorf; Thomas G Beach; Jeanne C Latourelle; Richard H Myers
Journal:  Front Aging Neurosci       Date:  2016-03-01       Impact factor: 5.750

Review 4.  Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson's Disease.

Authors:  Carla Ferreira; Catarina Almeida; Sandra Tenreiro; Alexandre Quintas
Journal:  Life (Basel)       Date:  2020-06-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.